Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses

BMJ (Online)

Volumn 340, Issue 7751, 2010, Pages 850-854

  Sun, Xin ^a,b   Briel, Matthias ^a,c   Walter, Stephen D ^a   Guyatt, Gordon H ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GEFITINIB; INSULIN; PLACEBO;

CANCER SURVIVAL; CHECKLIST; CLINICAL PRACTICE; CLINICAL TRIAL; DECISION MAKING; EVALUATION; HUMAN; INSULIN TREATMENT; INTENSIVE CARE UNIT; LUNG NON SMALL CELL CANCER; MANAGEMENT; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; REVIEW; RISK REDUCTION; SUBGROUP ANALYSIS;

DATA INTERPRETATION, STATISTICAL; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 77951082212     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c117     Document Type: Review

References (33)

1. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355:1064-1069 (Pubitemid 30162810)
2. Bhandari M, Devereaux PJ, Li P, Mah D, Lim K, Schunemann HJ, et al. Misuse of baseline comparison tests and subgroup analyses in surgical trials. Clin Orthop Relat Res 2006;447:247-251 (Pubitemid 44324921)
3. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine - reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357:2189-2194 (Pubitemid 350146117)
4. Guyatt G, Wyer PC, Ioannidis J. When to believe a subgroup analysis. In: Guyatt G, Rennie D, Meade MO, Cook DJ, eds. User's guide to the medical literature: a manual for evidence-based clinical practice. 2nd ed. AMA, 2008: 571-583
5. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. J Clin Epidemiol 1996;49:395-400.
6. Altman DG. Within trial variation - a false trail? J Clin Epidemiol 1998;51:301-303
7. Feinstein AR. The problem of cogent subgroups: a clinicostatistical tragedy. J Clin Epidemiol 1998;51:297-299
8. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. On reaching the tunnel at the end of the light. J Clin Epidemiol 1997;50:753-755
9. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. Clinical versus statistical considerations in the design and analysis of clinical research. J Clin Epidemiol 1998;51:305-307 (Pubitemid 28156047)
10. Senn S, Harrell F. On wisdom after the event. J Clin Epidemiol 1997;50:749-751
11. Smith GD, Egger M. Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses. J Clin Epidemiol 1998;51:289-295 (Pubitemid 28156044)
12. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991;266:93-98
13. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med 1992;116:78-84.
14. Akl EA, Terrenato I, Barba M, Sperati F, Sempos EV, Muti P, et al. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. Arch Intern Med 2008;168:1261-1269 (Pubitemid 351930830)
15. Billingham LJ, Cullen MH. The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer. Ann Oncol 2001;12:1671-1675 (Pubitemid 34105655)
16. Bundy DG, Berkoff MC, Ito KE, Rosenthal MS, Weinberger M. Interpreting subgroup analyses: is a school-based asthma treatment program's effect modified by secondhand smoke exposure? Arch Pediatr Adolesc Med 2004;158:469-471 (Pubitemid 38623584)
17. Cranney A, Tugwell P, Wells G, Guyatt G. Meta-analyses of therapies for postmenopausal osteoporosis *I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology. Endocr Rev 2002;23:496-507.
18. Freemantle N. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ 2001;322:989-991 (Pubitemid 32374693)
19. Hatala R, Keitz S, Wyer P, Guyatt G, for the Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine. 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ 2005;172:661-665
20. Heckman GA, McKelvie RS. Necessary cautions when considering digoxin in heart failure. CMAJ 2007;176:644-645
21. Kirpalani H, Barks J, Thorlund K, Guyatt G. Cooling for neonatal hypoxic ischemic encephalopathy: do we have the answer? Pediatrics 2007;120:1126-1130 (Pubitemid 350085552)
22. Jaeschke R, O'Byrne PM, Mejza F, Nair P, Lesniak W, Brozek J, et al. The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med 2008;178:1009-1016
23. Szczurko O, Cooley K, Busse JW, Seely D, Bernhardt B, Guyatt GH, et al. Naturopathic care for chronic low back pain: a randomized trial. PLoS One 2007;2:e919.
24. Bhandari M, Guyatt G, Tornetta P 3rd, Schemitsch EH, Swiontkowski M, Sanders D, et al. Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. J Bone Joint Surg Am 2008;90:2567-2578
25. Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:2307-2313 (Pubitemid 44833354)
26. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461 (Pubitemid 43200296)
27. Chan A-W. Bias, spin, and misreporting: time for full access to trial protocols and results. PLoS Med 2008;5:e230.
28. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887 (Pubitemid 351397087)
29. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306-313 (Pubitemid 43112959)
30. Ridker PM, Cook NR, Buring JE. Use of aspirin as primary prevention of cardiovascular events. JAMA 2006;296:391.
31. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004;66:411-421
32. Thatcher N, Chang A, Parikh P, Rodrigues Pereira J, Ciuleanu T, von Pawel J, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005;366:1527-1537 (Pubitemid 41540110)
33. Dans AL, Dans LF, Guyatt G. Applying results to individual patients. In: Guyatt G, Rennie D, Meade MO, Cook DJ, eds. User's guide to the medical literature: a manual for evidence-based clinical practice. 2nd ed. AMA, 2008: 273-289